Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:49:52.069Z.
Calculation as of: 2026-10-06T19:49:52.069Z.
Quote observation: 2026-10-06T19:38:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cafac005872c57a3e4a0b6cd3f460881363b31539507c7b963fc5044b4159481
EARNINGS YIELD
N/A
Market Cap
$481786.00
Earnings Yield
N/A
TTM Avg
79.57%
3Y Avg
139.63%
5Y Avg
139.63%
Market Cap
$356454.00
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$715847.00
Earnings Yield
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$814420.00
Earnings Yield
N/A
TTM Avg
233.12%
3Y Avg
232.94%
5Y Avg
366.47%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | $527596.00 | N/A | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | N/A | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A | 79.57% | 139.63% | 139.63% |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $701131.00 | N/A | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $356454.00 | N/A | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $715847.00 | N/A | 0.00% | 0.00% | 0.00% |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $814420.00 | N/A | 233.12% | 232.94% | 366.47% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827668.00 | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute